Molecular Partners AG (MOLN)

NASDAQ

Molecular Partners AG is a clinical-stage biopharmaceutical company. The company is headquartered in Schlieren, Switzerland.

Sector:

Industry:

68 analysts

Buy

Target: $11.06 (+176.50%)

Market Cap

$147M

Free Cash Flow Yield

-46.43%

Beta (5Y)

0.64

Adjust inflation

Log

Valuation

Market Cap$147M

Forward P/E1.70

P/S156.56

P/B1.77

Profitability

Gross Profit (TTM)-$46M

EBITDA-$78M

EPS-$2.16

Financial Health

Debt-to-Equity4.9%

Free Cash Flow Yield-46.43%

Growth & Risk

EPS 5Y CAGR-4.97%

FCF 5Y CAGR+2.57%

Beta (5Y)0.64

Sharpe Ratio0.38